The Latest in Breast Cancer ICYMI

‘Clear answer’: ALL study defies conventional wisdom

December 11, 2022

‘Astonishing’ results: Skip salvage chemo, proceed to HSCT

December 11, 2022

Post-transplant diet: Gruel no longer rules

December 11, 2022

Global effort needed to widen access to HSCT

December 10, 2022

Poorly matched stem cell transplants linked to ancestry

December 10, 2022

For minorities with PE: Less advanced treatment, more mortality

December 10, 2022

Guideline stresses new strategies for hypoglycemia management

December 9, 2022

Study implicates myelin plasticity in absence seizures

December 9, 2022

Newer brand-name drugs fuel spending on antiseizure medications

December 9, 2022

Oral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancer

December 9, 2022

Chemotherapy meets its match against aggressive ER+/HER2– breast cancers

December 9, 2022

Potential cause of worse outcomes among Black breast cancer patients found

December 9, 2022

Know the right resuscitation for right-sided heart failure

December 8, 2022

Current alopecia areata options include old and new therapies

December 8, 2022

Paxlovid has been free so far. Next year, sticker shock awaits

December 8, 2022